IMMUNOVEDA
Dead / Abandoned — Abandoned — failure to respond (as of 01 Sept 2023)
What this means for you
This application is over — abandoned 21 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90240324
- Mark type
- Design + words
- Filed
- 07 Oct 2020
- Published for opposition
- 13 Apr 2021
- Abandoned
- 21 Aug 2023
- Attorney of record
- Arnold Braun
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical diagnosis and treatment of Cancer; Medical diagnosis of Cancer; Medical analysis services for the diagnosis of cancer
Owner
- Genesis Drug, Discovery & Development, LLC, Hamilton, NJ, US
- Genesis Drug, Discovery & Development, LLC, Hamilton, NJ, US
Prosecution history
- 01 Sept 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Sept 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 01 Sept 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 18 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 May 2023 — NON-FINAL ACTION E-MAILED
- 18 May 2023 — SU - NON-FINAL ACTION - WRITTEN
- 24 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Apr 2023 — USE AMENDMENT FILED
- 24 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Apr 2023 — TEAS STATEMENT OF USE RECEIVED
- 16 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2022 — SOU EXTENSION 3 GRANTED
- 14 Sept 2022 — SOU EXTENSION 3 FILED
- 14 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 02 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED